Delivery Order SPE2DR25D2012-SPE2DR26F1BTU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,577.55 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100, with an ultimate completion date of October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,174.34 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,456.56 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with no set-aside designation, meaning the contract was awarded through full and open competition. The awardee will perform this contract from its corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) with a ceiling value of $1,229.86. The award, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,375.62 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. The contract utilizes firm fixed price pricing and was competitively awarded without a set-aside designation. The order was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,019.18 to Amerisourcebergen Drug Corp for the supply of Glimepiride 2 mg tablets (100-count packages) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside contract represents a task order under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031....
- The Defense Logistics Agency awarded a delivery order valued at $2,771.49 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on December 5, 2025, with completion targeted for December 8, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,686.62 to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg on November 25, 2025, with completion scheduled for November 26, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Glimepiride is an oral antidiabetic medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,259.83 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,950.40 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitive, non-set-aside award reflects a firm fixed-price contract type and represents a routine pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The contract is executed as a child delivery order under...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BTUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,950.84 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of January 16, 2026. The contract has no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, particularly those supporting military and veteran populations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical supply vehicle. The IDC enables the contractor to provide a broad range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. Glimepiride is a commonly prescribed diabetes medication, consistent with the contractor's extensive portfolio of medications across multiple therapeutic domains delivered through this federal supply arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/14/26 |